Oncternal Therapeutics In...

NASDAQ: ONCT · Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM

Oncternal Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.8 -1.21 -23.37
PEG Ratio
0.04 -0.00 -0.13
PS Ratio
40.15 35.30 169.54
PB Ratio
1.05 -0.33 -6.41
P/FCF Ratio
-0.98 -1.43 -27.51
P/OCF Ratio
-0.98 -1.43 -27.51
OCF/S Ratio
-40.97 -24.63 -6.16
Debt / Equity Ratio
0.01 -0.00 -0.00
Quick Ratio
6.94 8.75 17.16
Current Ratio
6.94 8.76 16.99
Asset Turnover
0.02 0.02 0.05
Interest Coverage
n/a n/a n/a
Return on Equity
-1.31 0.27 0.27
Return on Assets
-1.07 -0.63 -0.33
Return on Invested Capital
-1.32 -0.72 -0.36
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
-36.9 0.88 0.96
Net Profit Margin
-50.29 -29.12 -7.25
Pretax Profit Margin
-50.29 -29.64 -7.26
Operating Profit Margin
-53.14 -30.17 -7.27
FCF Margin
n/a n/a n/a
EBITDA Margin
2.85 -30.17 -7.27